Better Marijuana Stock Right Today: Tilray vs Trulieve
Investors are weighing Tilray and Trulieve to find the better marijuana stock right now. This guide breaks down funda...
Why Active Funds May Underperform Benchmarks discusses persistent headwinds, costs, and timing issues that hinder outperformance.
26,804 articlesInvestors are weighing Tilray and Trulieve to find the better marijuana stock right now. This guide breaks down funda...
A famous K-pop star’s stalker case isn’t just a headline. It exposes the hidden costs of personal security, legal bat...
A high-profile tech founder says America’s universities aren’t teaching practical engineering, risking a talent gap a...
Billionaire investor Mark Cuban argues the current economics of AI agents create a meaningful short-term counter to j...
Geopolitical conflicts are upending the classic playbook for U.S. stocks. The S&P 500 has not followed the traditiona...
Magnolia (MGY) is delivering a pivotal Q1 2026 performance that tests the durability of its business model. This arti...
As Hovnanian prepares to report Q2 2026 earnings, investors will scrutinize backlog, margins, and guidance. This anal...
USO has surged nearly 100% this year as Hormuz shutdowns persisted. A reopening could spark a swift unwind.
Cerebras stock is catching attention this week as analysts initiate coverage and AI demand grows. This article breaks...
Nvidia announces a breakthrough that isn’t a chip, signaling a new era for AI infrastructure. Investors react as data...
A ten-day residency in Amsterdam by a global pop star pushed hotel demand and prices higher, with a Gen Zer paying $1...
Goosehead (GSHD) is shaping its 2025 earnings trajectory with a blend of agency growth and tech-enabled efficiency. T...